The tenth anniversary of professional award in Russian pharmaceutical industry “Platinum Ounce 2009” was held on 22nd of April in Moscow. This prize is awarded on the basis of open completion and shows the best companies and the best trends in the pharmaceutical market of Russian Federation.
Traditional nominations of “Platinum Ounce” are “Project of the Year”, “Medicine of the Year”, “Company of the Year”, “Person of the Year”, “Employer of the Year” and many others. Moreover, the special commemorative prizes “Person of the decade”, “Medicine of the decade”, and “Company of the decade” were awarded this year. It should be noted that the winners are decides not only by the advisory council of professionals who evaluates nominees according to the strict criteria, but also by the results of internet voting.
This year “Platinum Ounce” award in the special category of the organizing committee for the “Successful implementation of projects on modernization of pharmaceutical production in Russian Federation in accordance with the standards GMP” received company FAVEA. This significant prize was given for more than ten-year history of many successful projects on construction and reconstruction of pharmaceutical production in accordance with modern standards of Good Manufacturing Practice (GMP).
For FAVEA this “Platinum Ounce” award means recognition of the work and contribution to the development of the Russian pharmaceutical industry. The general director of FAVEA Engineering Rus, Vladislav Kleandrov said: “I am in particularly pleased to receive this prestigious award from the hands of Igor Krylov, CEO of OAO “Pharmstandard”, one of our key customers”.
Details on competition as well as a list of all nominees and winners are on the official web site of the award.
This year “Platinum Ounce” award in the special category of the organizing committee for the “Successful implementation of projects on modernization of pharmaceutical production in Russian Federation in accordance with the standards GMP” received company FAVEA
Video
Opening of a new pharmaceutical production in Kazan
The new production of growth hormone RASTAN in Ufa
The worldwide most important document in determining the requirements for production and quality control of medicines for humans and animals is "Good Manufacturing Practice for Medicinal Products (GMP)".
Validation
In the methodological guidance we take into account the most recent issues of the national normative documents, the recommendations of the World Health Organization (WHO) and the Convention on mutual recognition of inspections in ...
GMP Training
The purpose of this training is to deepen the fundamental knowledge and expertise on the development of modern pharmaceuticals, manufacturing and quality control. Important objective is to train the personnel, ...